Clinical Trials Logo

Tracheostomy Infection clinical trials

View clinical trials related to Tracheostomy Infection.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06121440 Not yet recruiting - Clinical trials for Tracheostomy Infection

The Effect of an Audiobook and a Music-Movement Toy on Fear, Anxiety and Pain in Tracheostomy Care for Children in the Palliative Clinic

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

The aim of this study was to determine the effect of audio book and musical-moving toy on fear, anxiety and pain in tracheostomy care of children in palliative clinic.

NCT ID: NCT05113329 Not yet recruiting - Clinical trials for Tracheostomy Infection

Infection Control Program in Tracheostomized Patients

Start date: June 1, 2022
Phase:
Study type: Observational

Healthcare-associated infections are infections that patients acquire during the course of receiving treatment for other conditions within a healthcare setting and are not present at the time of admission. Medical instrumentation increases the risk of development of HAIs. Such devices include, venous and urinary catheters, and ventilators. Most ventilator-dependent patients undergo respiratory stabilization with an endotracheal tube in a critical care setting. Later on, translaryngeal tubes are converted to a tracheostomy to provide long-term airway access for ventilatory support. Tracheostomy is a commonly performed airway surgery for critically ill patients. It has variable complications, a common one being secondary infection with bacteria and fungi, which in turn leads- to granulation formation in stoma and on peristomal region. The risk factor for infection in patients with tracheostomy occurs due to exposure to large amounts of bacteria because they do not pass through the upper airway defense system. The commonest microorganism colonizing the tracheostomy tube leading to respiratory infections include Pseudomonas aeurginosa, Acinetobacter baumanii, and methicillin resistant Staphylococcus aureus, some of these organisms are antibiotic resistant. Biofilm formation is a unique self-protective mechanism of bacteria, protects them from host immune response and antimicrobial agents. Studies showed that more than 60% of hospital acquired infections are caused by biofilm forming bacteria on medical devices. These infections are most commonly attributed to Staphylococcus aureus, Pseudomonas, and mixed flora.